Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00513708 · ClinicalTrials.gov registry record · NA

Facilitating Aftercare for Alcohol Detox Patients

A NA study of Alcohol Abuse and Alcohol Dependence, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT00513708: Completed NA study of Alcohol Abuse and Alcohol Dependence, sponsored by State University of New York at Buffalo.

NCT00513708 is a NA study of Alcohol Abuse and Alcohol Dependence that has completed, run by State University of New York at Buffalo. The registered enrollment target is 150 participants, below the 710-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00513708, a NA study of Alcohol Abuse and Alcohol Dependence, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether peer visits (known as "12th Step Calls") and professional counselors (using "Motivational Enhancement Therapy") are effective helping alcoholics link to substance abuse treatment programs after being in the hospital for detox.

Primary Outcome

Linkage to alcohol behavioral therapy counseling (i.e., "aftercare") was defined as: arriving for the first outpatient chemical dependency counseling visit, being admitted to an inpatient or residential chemical dependency treatment facility, or attending at least one meeting of a help-help program such as Alcoholics Anonymous.

Interventions

  • BEHAVIORAL Motivation Enhancement Therapy (MET)
  • BEHAVIORAL Peer-Twelve Step Facilitation (P-TSF)

Study Locations (1)

New York

  • Erie County Medical Center - Buffalo

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2007-07
Est. Completion 2008-08
Phase NA

What the finished NCT00513708 record still lists

NCT00513708 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 710-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (79% lower).

The record links to 2 conditions, with Alcohol Abuse appearing as the primary indexed condition, and to 2 interventions - of which Motivation Enhancement Therapy (MET) is the first listed.

NCT00513708 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00513708 about?

NCT00513708 is a clinical study titled "Facilitating Aftercare for Alcohol Detox Patients". The purpose of this study is to determine whether peer visits (known as "12th Step Calls") and professional counselors (using "Motivational Enhancement Therapy") are effective helping alcoholics link to substance abuse treatment programs after being in the hospital for detox.

What is the current status of trial NCT00513708?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2007-07. Estimated completion is 2008-08.

What conditions does trial NCT00513708 study?

This clinical trial studies the following conditions: Alcohol Abuse, Alcohol Dependence.

What interventions are being tested in trial NCT00513708?

The interventions under investigation include: Motivation Enhancement Therapy (MET) (BEHAVIORAL), Peer-Twelve Step Facilitation (P-TSF) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00513708?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00513708 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Abuse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00513708's enrollment target sits among peer trials

150 24th of 46 higher than 23 of 46 other Alcohol Abuse trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00513708, the US trial registry maintained by the National Library of Medicine. NCT00513708 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.